
Retatrutide 20mg supplied as a lyophilised laboratory research material. UK-based stock with batch traceability and independent analytical testing programme. Research use only.
In stock
Retatrutide is a synthetic peptide studied in laboratory research for its activity across GIP, GLP-1 and glucagon receptor signalling pathways. Research focuses on multi-receptor agonism, cellular signalling and mechanisms associated with metabolic regulation. VOREVIA supplies this material strictly for laboratory research and analytical investigation. It is not for human consumption, therapeutic, diagnostic or veterinary use.